Pharmacytimes: Condition Center: Hepatitis C Hepatitis C en-us Sat, 01 Aug 2015 07:59:02 UTC Sat, 01 Aug 2015 07:59:02 UTC New Drugs Health-System Pharmacists Should Know Here are new drugs for 2015 pharmacists can expect to handle. Thu, 18 Jun 2015 04:26:00 UTC Costly Hepatitis C Drugs Pose Pharmacy Budget Problems for Prisons Treating prisoners for hepatitis C virus can be a costly nightmare, straining prisons’ pharmacy and health care budgets. Sun, 12 Apr 2015 05:00:00 UTC New Hepatitis C Regimens Have Adherence Issues Advances in treatment for chronic hepatitis C virus have been breaking news in the last few years. Wed, 01 Apr 2015 03:00:00 UTC Researchers Identify How Hepatitis Leads to Liver Cancer A recent study has identified how chronic hepatitis infection can pave the way to liver cancer. Fri, 06 Feb 2015 04:18:00 UTC How Hepatitis C Therapies are Changing Patient Treatment Eric Tichy, PharmD, BCPS, FCCP, senior clinical pharmacy specialist at Yale New-Haven Hospital, explains how hepatitis C therapies are changing patient treatment. Sat, 10 Jan 2015 02:18:00 UTC More Awareness of Hepatitis C Patients Needed A new study has revealed that many patients infected with the hepatitis C virus do not seek treatment and become lost in the different stages of health care to manage the disease. Wed, 24 Dec 2014 01:32:55 UTC Researchers Set to Study Hepatitis C Therapy in Children Researchers from Saint Louis University Medical Center will test the safety and efficacy of sofosbuvir and ribavirin in children with hepatitis C. Sat, 04 Oct 2014 01:40:59 UTC Polypharmacy Hinders HIV Drug Adherence Among HIV-positive patients, concurrent use of medications is associated with nonadherence to antiretroviral therapy. Sat, 27 Sep 2014 04:33:01 UTC Combination Treatment for HIV/HCV Coinfection Shown Effective in Phase 3 Trial Results of a phase 3 trial demonstrate the effectiveness of simeprevir in combination with ribavirin and peginterferon as a treatment for patients coinfected with HIV and HCV. Tue, 16 Sep 2014 02:56:43 UTC Hepatitis C Patients with HIV Co-Infection Vulnerable to Serious Liver Disease Despite Antiretroviral Therapy A study finds that patients co-infected with hepatitis C and HIV who are receiving antiretroviral therapy are 80% more likely to have serious liver disease than those with hepatitis C alone. Fri, 23 May 2014 01:00:54 UTC Multiple Tactics Needed to Combat Hepatitis C in Young Drug Users With hepatitis C infections on the rise among young injection drug users, researchers have recommended a range of promising prevention tactics. Wed, 07 Aug 2013 04:16:31 UTC Task Force Recommends Hepatitis C Testing for Baby Boomers The U.S. Preventive Services Task Force recommends that all patients born between 1945 and 1965 as well as high-risk patients of all ages be tested for hepatitis C. Tue, 09 Jul 2013 07:57:10 UTC CDC Urges All Baby Boomers to Get Tested for Hepatitis C Testing baby boomers could help identify more than 800,000 new cases of hepatitis C and address the largely preventable consequences of the condition. Fri, 08 Jun 2012 04:46:49 UTC Triple Therapy for Hepatitis C Can Be Cost-Effective New triple-therapy regimens for hepatitis C are expensive, but they can be cost-effective for many patients. Mon, 27 Feb 2012 05:20:09 UTC Risk Factors for Hepatitis C Fri, 24 Feb 2012 06:43:17 UTC New Drugs for Hepatitis C Fri, 24 Feb 2012 06:27:22 UTC The Promise of Interferon-Free Treatment Regimens for Hepatitis C Fri, 24 Feb 2012 05:37:42 UTC New Hepatitis C Treatment Fri, 24 Feb 2012 04:53:59 UTC Hepatitis C: Know Your Status Fri, 24 Feb 2012 04:43:42 UTC Hepatitis C: The Basics Fri, 24 Feb 2012 04:31:20 UTC